RUCCI, NADIA
 Distribuzione geografica
Continente #
NA - Nord America 11.508
EU - Europa 4.890
AS - Asia 4.769
SA - Sud America 572
Continente sconosciuto - Info sul continente non disponibili 155
AF - Africa 61
OC - Oceania 11
Totale 21.966
Nazione #
US - Stati Uniti d'America 11.367
SG - Singapore 1.926
CN - Cina 1.156
RU - Federazione Russa 1.034
IE - Irlanda 963
IT - Italia 672
TR - Turchia 547
DE - Germania 544
BR - Brasile 500
HK - Hong Kong 445
VN - Vietnam 405
SE - Svezia 358
GB - Regno Unito 340
UA - Ucraina 310
FR - Francia 251
FI - Finlandia 194
CA - Canada 83
IN - India 79
NL - Olanda 56
BD - Bangladesh 48
JP - Giappone 42
PL - Polonia 33
MX - Messico 30
BE - Belgio 25
AR - Argentina 22
ES - Italia 22
AT - Austria 21
ZA - Sudafrica 21
LT - Lituania 20
CZ - Repubblica Ceca 17
IQ - Iraq 14
MA - Marocco 14
KR - Corea 13
EC - Ecuador 12
VE - Venezuela 12
ID - Indonesia 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
AU - Australia 9
UZ - Uzbekistan 9
EG - Egitto 8
CO - Colombia 7
CL - Cile 6
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
IL - Israele 5
JO - Giordania 5
DO - Repubblica Dominicana 4
GR - Grecia 4
HN - Honduras 4
PA - Panama 4
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
LV - Lettonia 2
MK - Macedonia 2
PE - Perù 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 21.806
Città #
Dallas 3.258
Jacksonville 1.205
Singapore 1.138
Chandler 1.039
Dublin 961
San Jose 854
Ashburn 610
Hong Kong 438
Boardman 435
Santa Clara 426
Council Bluffs 307
Izmir 261
Nanjing 240
San Mateo 227
The Dalles 222
New York 213
L’Aquila 184
Wilmington 169
Lawrence 165
Princeton 165
Moscow 158
Beijing 133
Lauterbourg 123
Ho Chi Minh City 118
Ann Arbor 106
Milan 102
Los Angeles 91
Hanoi 89
Nanchang 85
L'aquila 67
São Paulo 67
Munich 61
Hefei 55
Rome 53
Shenyang 53
Seattle 49
Dong Ket 48
Woodbridge 47
Tianjin 45
Guangzhou 43
Bremen 42
Tokyo 41
Hebei 40
Amsterdam 37
Verona 35
Kitzingen 33
Kunming 32
Des Moines 31
Shanghai 31
Mountain View 29
Orem 29
Toronto 29
Falkenstein 28
Jiaxing 28
Columbus 27
Montreal 27
Warsaw 26
Norwalk 25
Phoenix 25
Brooklyn 24
Brussels 24
Chennai 24
Frankfurt am Main 24
Turku 24
Jinan 23
Helsinki 22
Chicago 21
San Francisco 20
Da Nang 19
Dearborn 19
Falls Church 19
Changsha 16
Teramo 16
Lanzhou 15
London 15
Philadelphia 15
Brno 14
Houston 14
Johannesburg 14
Mumbai 14
Ningbo 14
Zhengzhou 14
Atlanta 13
Canicattì 13
Denver 13
Lappeenranta 13
Pescara 13
Rio de Janeiro 13
Buffalo 12
Manchester 11
Nuremberg 11
Poplar 11
Taizhou 11
Tappahannock 11
Ankara 10
Belo Horizonte 10
Brasília 10
Stockholm 10
Boston 9
Mexico City 9
Totale 15.332
Nome #
(0) Save to: more options The matrix proline/arginine-rich end leucine-rich repeat protein (PRELP) inhibits osteoclastogenesis inactivating NF-kappaB signal 3.101
Ontogeny and regulation of variant thyroid hormone receptor isoforms in developing rat testis 190
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 183
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 166
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 165
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 160
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 151
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 151
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 150
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 146
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 145
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 144
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 141
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 141
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 141
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 141
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells 140
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 139
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 138
Bone cells and the mechanisms of bone remodelling 137
Non-conventional role of haemoglobin beta in breast malignancy 137
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 136
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 136
Ontogenesis and cell specific localization of Fas ligand expression in the rat testis 135
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 135
the effect of microgravity on osteoblast metabolism 135
The "love-hate" relationship between osteoclasts and bone matrix 135
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 133
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 133
Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis 132
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 131
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 130
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 130
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 129
Apoptosi e spermatogenesi: implicazioni fisiopatologiche 129
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 129
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 129
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 128
RNA methylation and cellular response to oxidative stress-promoting anticancer agents 127
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 127
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 127
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 126
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 126
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 126
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 126
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 123
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 123
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 122
Individualized Whole-Body Vibration: Neuromuscular, Biochemical, Muscle Damage and Inflammatory Acute Responses 122
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 121
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 121
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 121
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 121
C-SRC inhibition decreases breast cancer-induced lethality and incidence of experimental bone metastases in Balb nu/nu mice 120
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 120
The "soft" side of the bone: unveiling its endocrine functions. 120
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 120
A six-gene signature predicting breast cancer lung metastasis 119
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 119
Imbalance of osteoclastogenesis-regulating factors in celiac disease 118
Bone phenotype of IL-6 transgenic mice mimicking human chronic inflammatory diseases in children 117
Extracellular Vesicles in Bone Tumors: How to Seed in the Surroundings Molecular Information for Malignant Transformation and Progression 117
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 116
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 116
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 115
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 115
Switching homes: how cancer moves to bone 114
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 113
c-Src inhibition as a possible therapy against human breast cancer and bone metastases. 113
Osteoblast-derived extracellular vesicles influence MNNG/HOS osteosarcoma cells, reducing their migration and affecting their metabolic activity and redox balance 113
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 112
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 111
Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles 110
HistoEnder: a 3D printer-based histological slide autostainer that retains 3D printer functions 110
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma 110
Bone metastasis pain, from the bench to the bedside 110
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology 110
Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance 108
Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity 108
A model for in vitro three dimensional cultures of osteoblast-like cells 108
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 107
inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases 106
How the "seed" prepares the "soil": The bone/bone marrow pre-metastatic niche 106
Cytokine imbalance in Celiac disease and parallel direct stimulation of osteoclastogenesis and osteoblast activity in vitro. 105
Osteoclast receptors and signaling 105
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 104
Alternative TrkA splicing and Cancer 104
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 103
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 103
Circulating Extracellular Vesicles Express Receptor Activator of Nuclear Factor κB Ligand and Other Molecules Informative of the Bone Metabolic Status of Mouse Models of Experimentally Induced Osteoporosis 103
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice 102
Osteomimicry: how tumor cells try to deceive the bone 101
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 101
Effectiveness Of Osteotropic Nanoparticles On Bone Metastases 101
Tumour-derived extracellular vesicles (EVs): A dangerous “message in a bottle” for bone 101
Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and –beta during human testicular development and disease 99
Thyroid hormone modulation of aromatase activity and expression in mouse granulosa cells 99
A Combined Fc-OPG/hPTH(1-34) Therapy to Restore Impaired Skeletal Growth and Bone Loss in a Mouse Model of IL-6 Dependent Juvenile Inflammatory Diseases 99
Bone and bone marrow: the same organ 98
Totale 15.348
Categoria #
all - tutte 83.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022872 0 96 136 58 38 25 20 61 70 22 79 267
2022/20232.962 202 143 29 323 315 331 12 214 1.236 21 86 50
2023/2024928 228 55 42 119 69 212 7 43 4 25 16 108
2024/20253.022 54 48 291 145 397 290 386 275 590 159 224 163
2025/20268.980 344 1.030 2.509 904 514 499 1.083 225 519 778 458 117
2026/2027521 160 361 0 0 0 0 0 0 0 0 0 0
Totale 21.966